Jacobson Center for Clinical & Translational Research

Main Menu


Additional Information


Contact Us

Epilepsy Research Studies

Study Title:  A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sage-547                          Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus.  (Identifier: NCT02477618)

Study Purpose:  This is a randomized, double-blind, placebo-controlled trial, designed to evaluate the efficacy and safety of SAGE-547 administered as a continuous intravenous infusion to subjects in Super-Refractory Status Epilepticus (SRSE).

Principal Investigator: Imran Ali, M.D.

Study Coordinator: Megan Murphy, for more information, please call 419-383-4516

Last Updated: 4/20/16